Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.
PDL BioPharma Inc PDLI has a PEG ratio of 0.27. PDLI's trailing-twelve-month operating margin is 89.34%.
Exelixis Inc EXEL has a PEG ratio of 0.33. EXEL's trailing-twelve-month revenue is $188.35 million.
ShangPharma Corporation America SHP has a PEG ratio of 0.68. SHP's trailing-twelve-month profit margin is 15.35%.
ViroPharma Incorporated VPHM has a PEG ratio of 0.87. VPHM's trailing-twelve-month operating margin is 46.83%.
Trading Ideas.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in